Oligo therapeutics and delivery

Sponsored By 

Speaker - Funded(s)

• 

  Audrey Gallud, PhD

  Associate Principal Scientist
  AstraZeneca
  MOLNDAL, Vastra Gotaland, Sweden
• 

  Piotr Kowalski (he/him/his)

  Associate Professor
  University College Cork
  CORK, Ireland

Speaker - Tony B. Awardee(s)

• 

  Joel Sanchez Barea

  PhD Candidate
  Incheon National University
  Incheon, Inch'on-jikhalsi, Republic of Korea

The recent success of Covid-19 vaccines has unravelled the pharmaceutical potential of both mRNA and non-viral delivery systems. Transforming a formulated mRNA into an effective drug has been a tremendous effort. These achievements should further facilitate the development of therapies based on the same technology. This session will focus on the recent advances in the field, and it will highlight existing challenges and potential solutions to those.

Presentations:

• 11:30 – 12:00 CEST

  LNP Formulation Development through Innovative DMTA Technologies
  

  Audrey Gallud, PhD – AstraZeneca
• 12:00 – 12:30 CEST

  Engineering circular RNA nanotherapeutics
  

  Piotr S. Kowalski (he/him/his) – University College Cork
• 12:30 – 13:00 CEST

  Multiplexed detection of single-point mutations in human serum by integrating Surface Enhanced Raman Scattering with Polymerase Chain Reaction.
  

  Joel Sanchez Barea – Incheon National University